AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: platform biotechClear filter
industryEurekAlert!

Insilico Medicine’s Longevity Board Shows the Company Wants to Own Aging Biology, Not Just Drug Discovery

Insilico Medicine has launched what it says is the industry’s first longevity board to accelerate AI-driven aging research. The move reflects a broader push to turn AI platforms into long-horizon biology engines, not just single-program discovery tools.

Insilico Medicinelongevityaging biologydrug discovery
industry

Recursion’s Roche Signal Highlights Big Pharma’s Ongoing Appetite for AI Discovery Platforms

New investor-focused coverage of Recursion Pharmaceuticals points to continued attention on Roche’s commitment to AI-enabled drug development. The story is less about short-term stock moves than about whether major pharma companies are moving from exploratory partnerships to sustained platform dependence.

Quiver Quantitative
Recursion PharmaceuticalsRocheAI drug discovery

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.